<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Katzen J</submitter><funding>BLRD VA</funding><funding>NHLBI NIH HHS</funding><pagination>e2123187119</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9618079</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>119(43)</volume><pubmed_abstract>Disruption of alveolar type 2 cell (AEC2) protein quality control has been implicated in chronic lung diseases, including pulmonary fibrosis (PF). We previously reported the in vivo modeling of a clinical surfactant protein C (SP-C) mutation that led to AEC2 endoplasmic reticulum (ER) stress and spontaneous lung fibrosis, providing proof of concept for disruption to proteostasis as a proximal driver of PF. Using two clinical SP-C mutation models, we have now discovered that AEC2s experiencing significant ER stress lose quintessential AEC2 features and develop a reprogrammed cell state that heretofore has been seen only as a response to lung injury. Using single-cell RNA sequencing in vivo and organoid-based modeling, we show that this state arises de novo from intrinsic AEC2 dysfunction. T</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Disruption of proteostasis causes IRE1 mediated reprogramming of alveolar epithelial cells.</pubmed_title><pmcid>PMC9618079</pmcid><funding_grant_id>K08 HL150226</funding_grant_id><funding_grant_id>I01 BX005411</funding_grant_id><funding_grant_id>R01 HL087825</funding_grant_id><funding_grant_id>I01 BX001176</funding_grant_id><funding_grant_id>U01 HL134745</funding_grant_id><funding_grant_id>U01 HL152970</funding_grant_id><funding_grant_id>R01 HL132999</funding_grant_id><funding_grant_id>R01 HL152194</funding_grant_id><funding_grant_id>K08 HL163398</funding_grant_id><funding_grant_id>R01 HL145408</funding_grant_id><pubmed_authors>Rodriguez L</pubmed_authors><pubmed_authors>Beers MF</pubmed_authors><pubmed_authors>Katzen J</pubmed_authors><pubmed_authors>Carl J</pubmed_authors><pubmed_authors>Morley M</pubmed_authors><pubmed_authors>Pelura T</pubmed_authors><pubmed_authors>Rosen G</pubmed_authors><pubmed_authors>Leach JP</pubmed_authors><pubmed_authors>Mulugeta S</pubmed_authors><pubmed_authors>Zhao M</pubmed_authors><pubmed_authors>Carson P</pubmed_authors><pubmed_authors>Murthy A</pubmed_authors><pubmed_authors>Morrisey EE</pubmed_authors><pubmed_authors>Babu A</pubmed_authors><pubmed_authors>Barrett M</pubmed_authors><pubmed_authors>McGraw MD</pubmed_authors><pubmed_authors>Tomer Y</pubmed_authors><pubmed_authors>Basil MC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Disruption of proteostasis causes IRE1 mediated reprogramming of alveolar epithelial cells.</name><description>Disruption of alveolar type 2 cell (AEC2) protein quality control has been implicated in chronic lung diseases, including pulmonary fibrosis (PF). We previously reported the in vivo modeling of a clinical surfactant protein C (SP-C) mutation that led to AEC2 endoplasmic reticulum (ER) stress and spontaneous lung fibrosis, providing proof of concept for disruption to proteostasis as a proximal driver of PF. Using two clinical SP-C mutation models, we have now discovered that AEC2s experiencing significant ER stress lose quintessential AEC2 features and develop a reprogrammed cell state that heretofore has been seen only as a response to lung injury. Using single-cell RNA sequencing in vivo and organoid-based modeling, we show that this state arises de novo from intrinsic AEC2 dysfunction. T</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-04T07:11:09.724Z</modification><creation>2025-04-04T07:11:09.724Z</creation></dates><accession>S-EPMC9618079</accession><cross_references><pubmed>36252035</pubmed><doi>10.1073/pnas.2123187119</doi></cross_references></HashMap>